Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qishen Yiqi dripping pills versus Tongxinluo capsules for stable angina due to coronary heart disease
ChiCTR-TTRCC-13003732Phase 4Completed
- Sponsor
- Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine
- Start
- Dec 2013
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis and stable angina comparing Qishen Yiqi first with Tongxinluo first (2 arms). Primary endpoint: Seattle Angina Questionnaire score. Started Dec 2013; status: completed.
02
Drugs
qishen yiqi dripping pillsTongxinluo
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ChiCTR-TTRCC-13003732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TTRCC-13003732.